Literature DB >> 32937098

An insight into osteoarthritis susceptibility: Integration of immunological and genetic background.

Debora Stefik1, Vladimir Vranic2, Nemanja Ivkovic1, Dzihan Abazovic3, Dusan Maric4, Danilo Vojvodic5, Gordana Supic5.   

Abstract

Osteoarthritis (OA) is a progressive degenerative disease that affects all synovial joints, causing the disability of the main locomotor diarthrodial joints. OA pathogenesis is caused by a complex interplay between a number of genetic and environmental risk factors, involved in the early onset and progression of this chronic inflammatory joint disease. Uncovering the underlying immunological and genetic mechanisms will enable an insight into OA pathophysiology and lead to novel and integrative approaches in the treatment of OA patients, together with a reduction of the disease risk, or a delay of its onset in susceptible patients.

Entities:  

Year:  2021        PMID: 32937098      PMCID: PMC7982064          DOI: 10.17305/bjbms.2020.4735

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  77 in total

Review 1.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.

Authors:  J P Pelletier; J Martel-Pelletier; S B Abramson
Journal:  Arthritis Rheum       Date:  2001-06

2.  Association between ADAM12 polymorphism and knee osteoarthritis in Thai population.

Authors:  Thitiya Poonpet; Rachaneekorn Tammachote; Nattapol Tammachote; Supakit Kanitnate; Sittisak Honsawek
Journal:  Knee       Date:  2016-02-10       Impact factor: 2.199

Review 3.  The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive.

Authors:  Eric W Orlowsky; Virginia Byers Kraus
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

Review 4.  TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs.

Authors:  Rodolfo Gómez; Amanda Villalvilla; Raquel Largo; Oreste Gualillo; Gabriel Herrero-Beaumont
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

5.  Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells.

Authors:  Mostafa A Gabr; Liufang Jing; Antonia R Helbling; S Michael Sinclair; Kyle D Allen; Mohammed F Shamji; William J Richardson; Robert D Fitch; Lori A Setton; Jun Chen
Journal:  J Orthop Res       Date:  2011-01       Impact factor: 3.494

6.  TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways.

Authors:  Cheryle A Séguin; Suzanne M Bernier
Journal:  J Cell Physiol       Date:  2003-12       Impact factor: 6.384

7.  ADAM gene expression and regulation during human osteoclast formation.

Authors:  S Verrier; A Hogan; N McKie; M Horton
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

Review 8.  ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.

Authors:  C-Y Yang; A Chanalaris; L Troeberg
Journal:  Osteoarthritis Cartilage       Date:  2017-02-13       Impact factor: 6.576

9.  Menopause and Osteoarthritis: Any Association ?

Authors:  Annil Mahajan; Ranu Patni
Journal:  J Midlife Health       Date:  2018 Oct-Dec

10.  Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations.

Authors:  Mukundan Attur; Hwa-Ying Wang; Virginia Byers Kraus; Jack F Bukowski; Nazneen Aziz; Svetlana Krasnokutsky; Jonathan Samuels; Jeffrey Greenberg; Gary McDaniel; Steven B Abramson; Kenneth S Kornman
Journal:  Ann Rheum Dis       Date:  2009-11-23       Impact factor: 19.103

View more
  1 in total

1.  High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors.

Authors:  Tatjana Ullmann; Sonja Luckhardt; Markus Wolf; Michael J Parnham; Eduard Resch
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.